Former undocumented migrant named US bishop

Published
0

VATICAN CITY: Pope Leo XIV named a former undocumented migrant as bishop of West Virginia on Friday, weeks after a high-profile verbal confrontation with US President Donald Trump.

The US-born leader of the world’s 1.4 billion Cat­holics has been highly critical of Trump over immigration and the Middle East war.

The Vatican in a statement announced the nomination of 56-year-old Evelio Menjivar-Ayala, currently an auxiliary bishop in Washington.

Born in El Salvador, Me­­­n­­jivar-Ayala migrated to the US in 1990, according to a biography on the Wash­ington diocese website.

He has spoken in interviews about being born into poverty and fleeing conflict in his native country to arrive in the US as a refugee. After being initially detained in Mexico trying to get to the US, he said in an interview last year that he paid a bribe to get out and crossed the border at Tijuana.

He was ordained as a priest in 2004 and became a bishop in 2023.

Published in Dawn, May 2nd, 2026

Opinion

Editorial

Nuclear uncertainty
Updated 23 Oct, 2026

Nuclear uncertainty

With matters frozen in the political and diplomatic spheres, it will take military-to-military engagement to prevent miscalculation in the strategic sphere.
Auto illusion
23 Oct, 2026

Auto illusion

PAKISTAN’S draft auto policy 2026-31 is ambitious in its targets and directionless in its strategy. It promises...
Two crimes
23 Oct, 2026

Two crimes

THE senseless killing of a teenager by his employers in Multan is a crime that deserves unqualified condemnation. It...
Makkah pact clarity
Updated 22 Oct, 2026

Makkah pact clarity

Fresh aggression can kick off a firestorm that will be in no one’s control, hence it is best to abandon such reckless plans.
Common ground
Updated 22 Oct, 2026

Common ground

Regrettably, the two sides still fail to see the country’s economic, security, and governance crises as challenges that must be solved politically.
The treatment gap
22 Oct, 2026

The treatment gap

A BREAST cancer diagnosis no longer carries the bleak outlook it did a generation ago. Targeted medicines,...